A revolutionary handheld and battery-powered DNA diagnostic device invented at the University of Otago is poised to become a commonly used field tool for rapidly detecting suspected viruses or bacteria in samples while also determining the level of infection.
The breakthrough device, dubbed Freedom4, will be unveiled today at the Queenstown Molecular Biology main meeting. It takes advantage of a technology called quantitative PCR to identify target DNA sequences in real-time, without the need for further processing.
As an example, using Freedom4, the presence and extent of norovirus infection in a sample could be confirmed within less than an hour, while the person using the unit was still at the outbreak site.
Dr Jo-Ann Stanton, who led the programme to develop the device, says that as well as enabling ‘anytime, anywhere’ clinical diagnosis of viral infectious diseases in humans and animals, it also has many other potential uses, such as border security, forensics or environmental monitoring.
Developed by Dr Stanton’s multidisciplinary team at Otago’s Department of Anatomy, the sturdy unit weighs the same as a typical laptop and fits on the palm of your hand. Freedom4 boasts a six-hour battery life and can be tethered to a laptop, or connect wirelessly to smart phones or tablets running custom software that analyses and interprets the test results.
“This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analysing samples from various locations, make their diagnoses and treat infected animals-all in one trip,” she says.
The Latest on: DNA diagnostics
via Google News
The Latest on: DNA diagnostics
- Next-generation Cancer Diagnostics Market Growth Rate, Demands, Status And Application Forecast to 2024on October 14, 2021 at 4:09 pm
The cancer diagnostics industry is projected to witness lucrative growth in the next few years due to the increasing number of technologically advanced products providing accurate test results in the ...
- Global Oncology Molecular Diagnostics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.comon October 14, 2021 at 6:19 am
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026” report has been added to ResearchAndMarkets.com’s offering. The global oncology molecular diagnostics market is ...
- Outlook on the Oncology Molecular Diagnostics Global Market to 2026 - by Cancer Type, Product, Technology, End-user and Regionon October 14, 2021 at 12:33 am
The "Oncology Molecular Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global ...
- Lucid Diagnostics Announces Pricing of Initial Public Offeringon October 13, 2021 at 10:28 pm
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the ...
- Are diagnostic and public health bacteriology ready to become branches of genomic medicine?on October 13, 2021 at 9:15 pm
Diagnostic medical bacteriology is a conservative discipline. When busy house officers scribble 'M, C & S' on a form, they are requesting two techniques - microscopy and culture of microorganisms - ...
- DAF Awards $30 Million Contract to Eurofins Genomics to Expand Oligonucleotide (DNA) Capacity for Diagnostic Testingon October 13, 2021 at 7:48 am
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and ...
- SDX DNA of a Play: 49ers HOF WR John Taylor Breaks Down Historic Super Bowl XXIII Catchon October 12, 2021 at 10:26 pm
Taylor broke down his game-winning touchdown reception from Joe Montana that propelled San Francisco to its third Super Bowl title.
- GeneCentric Therapeutics Collaborates with Labcorp to Develop Novel RNA-Based Oncology Diagnosticson October 12, 2021 at 5:05 am
GeneCentric announced a new strategic collaboration with Labcorp to develop and commercialize new RNA-based gene signatures as cancer diagnostics.
- The global infectious disease diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to reach 41.6 billion by 2027.on October 12, 2021 at 2:48 am
The growth is primarily attributed to prevalence of infectious diseases global outbreak of COVID 19 technological advancements and increased demands for decentralized diagnostic POC kits However ...
- Direct-to-consumer DNA Testing market size to expand momentously over 2021-2026on October 12, 2021 at 1:52 am
The business intelligence report on Direct-to-consumer DNA Testing market entails a systematic analysis of the past and present business scenario ...
via Bing News